Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report-Reference-Cited by-同舟云学术

Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report

Published:2020-07-30 Issue:6 Volume:34 Page:883-885
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Karadeniz Hazan^ORCID,Yamak Betül Ayça,Özger Hasan Selçuk,Sezenöz Burak,Tufan Abdurrahman,Emmi Giacomo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-020-07044-3.pdf

Reference9 articles.

1. Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020;50(SI-1):620–32 Published 2020 Apr 21.

2. Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in covid-19 [published online ahead of print, 2020 Apr 30]. Heart. 2020; heartjnl-2020-317056.

3. Cizgici AY, Zencirkiran Agus H, Yildiz M. COVID-19 myopericarditis: it should be kept in mind in today's conditions. Am J Emerg Med. 2020;S0735-6757(20):30310–7.

4. Adler Y, Charron P, Imazio, et al. ESC guidelines for the diagnosis and management of pericardial diseases: the force for the diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;42:2921–64.

5. Buckley LF, Viscusi MM, Van Tassell BW, Abbate A. Interleukin-1 blockade for the treatment of pericarditis. Eur Heart J Cardiovasc Pharmacother. 2018;4(1):46–53.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pericardial and myocardial manifestations of COVID-19;COVID-19’s Consequences on the Cardiovascular System;2024

2. Therapy of pericarditis with colchicine, interleukin-1 antagonists, immunosuppressants;Clinical Medicine (Russian Journal);2023-03-26

3. Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra);Rheumatology Science and Practice;2023-03-03

4. Using Natural Language Processing for Context Identification in COVID-19 Literature;Advances in Bioinformatics and Computational Biology;2023

5. Acute Pericarditis as the Primary Presentation of COVID-19 Infection followed by Guillain-Barre Syndrome in a Healthy Young Man: A Case Report;The Open Respiratory Medicine Journal;2022-12-12